- Home
- CMMB vs BIYA Comparison
CMMB vs BIYA Comparison
Compare CMMB & BIYA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CMMB
- BIYA
- Stock Information
- Founded
- CMMB 2004
- BIYA 2017
- Country
- CMMB Israel
- BIYA China
- Employees
- CMMB N/A
- BIYA N/A
- Industry
- CMMB Biotechnology: Pharmaceutical Preparations
- BIYA
- Sector
- CMMB Health Care
- BIYA
- Exchange
- CMMB Nasdaq
- BIYA NYSE
- Market Cap
- CMMB 23.0M
- BIYA 61.6M
- IPO Year
- CMMB N/A
- BIYA 2025
- Fundamental
- Price
- CMMB $1.32
- BIYA $4.88
- Analyst Decision
- CMMB Strong Buy
- BIYA
- Analyst Count
- CMMB 2
- BIYA 0
- Target Price
- CMMB $8.50
- BIYA N/A
- AVG Volume (30 Days)
- CMMB 109.4K
- BIYA 298.0K
- Earning Date
- CMMB 05-15-2025
- BIYA 05-13-2025
- Dividend Yield
- CMMB N/A
- BIYA N/A
- EPS Growth
- CMMB N/A
- BIYA N/A
- EPS
- CMMB N/A
- BIYA N/A
- Revenue
- CMMB N/A
- BIYA $12,809,211.00
- Revenue This Year
- CMMB N/A
- BIYA N/A
- Revenue Next Year
- CMMB N/A
- BIYA N/A
- P/E Ratio
- CMMB N/A
- BIYA N/A
- Revenue Growth
- CMMB N/A
- BIYA 10.66
- 52 Week Low
- CMMB $0.78
- BIYA $1.21
- 52 Week High
- CMMB $2.55
- BIYA $8.00
- Technical
- Relative Strength Index (RSI)
- CMMB 50.69
- BIYA N/A
- Support Level
- CMMB $1.31
- BIYA N/A
- Resistance Level
- CMMB $1.44
- BIYA N/A
- Average True Range (ATR)
- CMMB 0.08
- BIYA 0.00
- MACD
- CMMB 0.00
- BIYA 0.00
- Stochastic Oscillator
- CMMB 54.55
- BIYA 0.00
About CMMB Chemomab Therapeutics Ltd.
Chemomab Therapeutics Ltd is a clinical-stage biotech company, focusing on the discovery and development of therapeutics for fibrosis-related diseases with large unmet needs. The company's candidate, CM-101, is a monoclonal antibody that targets CCL24 and was shown to interfere with the underlying biology of liver, skin, and lung fibrosis using a novel and differentiated mechanism of action. CM-101 has demonstrated the potential to treat multiple severe and life-threatening fibrotic and inflammatory diseases. It is advancing three Phase 2 clinical trials in parallel for CM-101, treating rare fibrotic conditions.
About BIYA BAIYA INTERNATIONAL GROUP INC
Baiya International Group Inc is a company which operates through its subsidiary Gongwuyuan operates a cloud-based internet platform to provide one-stop crowdsourcing recruitment and SaaS-enabled HR solutions in the flexible employment marketplace. The Company's business is focused around on four primary services which are job matching services, entrusted recruitment services, project outsourcing services and abor dispatching services in the flexible employment market within China, mainly in the core manufacturing regions including the Pearl River Delta and Yangtze River Delta region.